Cargando…

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma

OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ying, Li, Zhuo, Zhou, Yanzhao, Yang, Yi, Ouyang, Jingzhong, Li, Lu, Huang, Zhen, Ye, Feng, Ying, Jianming, Zhao, Hong, Zhou, Jinxue, Zhao, Xinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588260/
https://www.ncbi.nlm.nih.gov/pubmed/37858111
http://dx.doi.org/10.1186/s12885-023-11476-z
_version_ 1785123544056725504
author Xu, Ying
Li, Zhuo
Zhou, Yanzhao
Yang, Yi
Ouyang, Jingzhong
Li, Lu
Huang, Zhen
Ye, Feng
Ying, Jianming
Zhao, Hong
Zhou, Jinxue
Zhao, Xinming
author_facet Xu, Ying
Li, Zhuo
Zhou, Yanzhao
Yang, Yi
Ouyang, Jingzhong
Li, Lu
Huang, Zhen
Ye, Feng
Ying, Jianming
Zhao, Hong
Zhou, Jinxue
Zhao, Xinming
author_sort Xu, Ying
collection PubMed
description OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively included as training, external validation cohort. Clinical, radiological and pathological variables were evaluated and collected. Univariate and multivariate analysis were applied to select the significant factors related to VER of ICC. The factors selected were combined to perform stratification of overall survival (OS) using the Kaplan-Meier method with the log-rank test. RESULTS: Overall, 39 patients (24.4%) had VER, whereas 121 (75.6%) did not (non-VER group). In the training cohort, the median OS was 40.5 months (95% CIs: 33.2–47.7 months). The VER group showed significantly worse OS than the non-VER group (median OS: 14.8, 95% CI:11.6–18.0 months vs. 53.4, 34.3–72.6 months; p<0.001), and it was confirmed in the validation cohort (median OS: 22.1, 95% CI: 8.8–35.4 months vs. 40.1, 21.2–59.0 months; p = 0.003). According to the univariate analysis, four variables were significantly different between the VER group and non-VER group (TLSs status, p = 0.028; differentiation, p = 0.023; MVI status, p = 0.012; diameter, p = 0.028). According to the multivariate analysis, MVI-positive status was independently associated with a higher probability of VER (odds ratio [OR], 2.5; 95% CIs,1.16–5.18; p = 0.018), whereas intra-tumoral TLSs-positive status was associated with lower odds of VER (OR, 0.43; 95% CIs, 0.19–0.97; p = 0.041). Based on the TLSs and MVI status, patients of ICC were categorized into four groups: TLSs-positive and MVI-negative (TP/MN); TLSs-negative and MVI-negative (TN/MN); TLSs-positive and MVI-positive (TP/MP), TLSs-negative and MVI-positive groups (TN/MP). In the training cohort, the four groups could be correlated with OS significantly (p<0.001), and it was confirmed in the validation cohort (p<0.001). CONCLUSION: Intra-tumoral TLSs and MVI status are independent predictive factors of VER after surgery, based on which immunovascular stratifications are constructed and associated with OS significantly of resectable intrahepatic cholangiocarcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11476-z.
format Online
Article
Text
id pubmed-10588260
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105882602023-10-21 Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma Xu, Ying Li, Zhuo Zhou, Yanzhao Yang, Yi Ouyang, Jingzhong Li, Lu Huang, Zhen Ye, Feng Ying, Jianming Zhao, Hong Zhou, Jinxue Zhao, Xinming BMC Cancer Research OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. METHODS: A total of 160, 51 ICC patients from two institutions between May 2012 and July 2022 were retrospectively included as training, external validation cohort. Clinical, radiological and pathological variables were evaluated and collected. Univariate and multivariate analysis were applied to select the significant factors related to VER of ICC. The factors selected were combined to perform stratification of overall survival (OS) using the Kaplan-Meier method with the log-rank test. RESULTS: Overall, 39 patients (24.4%) had VER, whereas 121 (75.6%) did not (non-VER group). In the training cohort, the median OS was 40.5 months (95% CIs: 33.2–47.7 months). The VER group showed significantly worse OS than the non-VER group (median OS: 14.8, 95% CI:11.6–18.0 months vs. 53.4, 34.3–72.6 months; p<0.001), and it was confirmed in the validation cohort (median OS: 22.1, 95% CI: 8.8–35.4 months vs. 40.1, 21.2–59.0 months; p = 0.003). According to the univariate analysis, four variables were significantly different between the VER group and non-VER group (TLSs status, p = 0.028; differentiation, p = 0.023; MVI status, p = 0.012; diameter, p = 0.028). According to the multivariate analysis, MVI-positive status was independently associated with a higher probability of VER (odds ratio [OR], 2.5; 95% CIs,1.16–5.18; p = 0.018), whereas intra-tumoral TLSs-positive status was associated with lower odds of VER (OR, 0.43; 95% CIs, 0.19–0.97; p = 0.041). Based on the TLSs and MVI status, patients of ICC were categorized into four groups: TLSs-positive and MVI-negative (TP/MN); TLSs-negative and MVI-negative (TN/MN); TLSs-positive and MVI-positive (TP/MP), TLSs-negative and MVI-positive groups (TN/MP). In the training cohort, the four groups could be correlated with OS significantly (p<0.001), and it was confirmed in the validation cohort (p<0.001). CONCLUSION: Intra-tumoral TLSs and MVI status are independent predictive factors of VER after surgery, based on which immunovascular stratifications are constructed and associated with OS significantly of resectable intrahepatic cholangiocarcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11476-z. BioMed Central 2023-10-19 /pmc/articles/PMC10588260/ /pubmed/37858111 http://dx.doi.org/10.1186/s12885-023-11476-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Ying
Li, Zhuo
Zhou, Yanzhao
Yang, Yi
Ouyang, Jingzhong
Li, Lu
Huang, Zhen
Ye, Feng
Ying, Jianming
Zhao, Hong
Zhou, Jinxue
Zhao, Xinming
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title_full Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title_fullStr Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title_full_unstemmed Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title_short Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
title_sort using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588260/
https://www.ncbi.nlm.nih.gov/pubmed/37858111
http://dx.doi.org/10.1186/s12885-023-11476-z
work_keys_str_mv AT xuying usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT lizhuo usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT zhouyanzhao usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT yangyi usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT ouyangjingzhong usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT lilu usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT huangzhen usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT yefeng usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT yingjianming usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT zhaohong usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT zhoujinxue usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma
AT zhaoxinming usingimmunovascularcharacteristicstopredictveryearlyrecurrenceandprognosisofresectableintrahepaticcholangiocarcinoma